UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 4,092	$ 3,536
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	200	166
Amortization	570	508
Provision for (recovery of) losses on accounts receivable	1	(1)
Deferred income taxes	(76)	(118)
Stock-based compensation expense	30	36
Tax benefit attributable to exercise of stock options	16	10
Changes in operating assets and liabilities:
Accounts receivable	(560)	(934)
Accrued interest and other receivables	0	(5)
Inventories	(303)	(154)
Prepaid expenses and other current assets	(53)	(56)
Accounts payable	142	117
Accrued expenses	(293)	1,202
Total adjustments	(326)	771
Net cash provided by operating activities	3,766	4,307
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures for property and equipment	(173)	(65)
Net cash provided by (used in) investing activities	(173)	(65)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock - options	147	53
Payment of dividends	(1,005)	0
Net cash provided by (used in) financing activities	(858)	53
Effect of exchange rate changes on cash	243	88
Net increase (decrease) in cash and cash equivalents	2,978	4,383
Cash at beginning of period	39,875	26,296
Cash at end of period	42,853	30,679
Cash paid during the period for income taxes	788	442
Cash paid during the period for interest	$ 0	$ 0